Literature DB >> 15557013

Orexin stimulates breathing via medullary and spinal pathways.

John K Young1, Mingfei Wu, Kebreten F Manaye, Prabha Kc, Joanne S Allard, Serdia O Mack, Musa A Haxhiu.   

Abstract

A central neuronal network that regulates respiration may include hypothalamic neurons that produce orexin, a peptide that influences sleep and arousal. In these experiments, we investigated 1) projections of orexin-containing neurons to the pre-Botzinger region of the rostral ventrolateral medulla that regulates rhythmic breathing and to phrenic motoneurons that innervate the diaphragm; 2) the presence of orexin A receptors in the pre-Botzinger region and in phrenic motoneurons; and 3) physiological effects of orexin administered into the pre-Botzinger region and phrenic nuclei at the C3-C4 levels. We found orexin-containing fibers within the pre-Botzinger complex. However, only 0.5% of orexin-containing neurons projected to the pre-Botzinger region, whereas 2.9% of orexin-containing neurons innervated the phrenic nucleus. Neurons of the pre-Botzinger region and phrenic nucleus stained for orexin receptors, and activation of orexin receptors by microperfusion of orexin in either site produced a dose-dependent, significant (P <0.05) increase in diaphragm electromyographic activity. These data indicate that orexin regulates respiratory activity and may have a role in the pathophysiology of sleep-related respiratory disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557013     DOI: 10.1152/japplphysiol.00914.2004

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  55 in total

1.  Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex.

Authors:  Israt Z Shahid; Ahmed A Rahman; Paul M Pilowsky
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Functional link between the hypocretin and serotonin systems in the neural control of breathing and central chemosensitivity.

Authors:  Andrea E Corcoran; George B Richerson; Michael B Harris
Journal:  J Neurophysiol       Date:  2015-04-15       Impact factor: 2.714

Review 3.  State-dependent central chemoreception: a role of orexin.

Authors:  Tomoyuki Kuwaki; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2010-02-17       Impact factor: 1.931

4.  Optogenetic identification of hypothalamic orexin neuron projections to paraventricular spinally projecting neurons.

Authors:  Olga Dergacheva; Akihiro Yamanaka; Alan R Schwartz; Vsevolod Y Polotsky; David Mendelowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-02-03       Impact factor: 4.733

Review 5.  Central chemoreception in wakefulness and sleep: evidence for a distributed network and a role for orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  J Appl Physiol (1985)       Date:  2010-02-04

6.  Post-diaminobenzidine Treatments for Double Stainings: Extension of Sulfide-Silver-Gold Intensification for Light and Fluorescent Microscopy.

Authors:  Ibolya Török; György Seprényi; Erzsébet Pór; Emőke Borbély; Titanilla Szögi; Endre Dobó
Journal:  J Histochem Cytochem       Date:  2020-07-13       Impact factor: 2.479

Review 7.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 8.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

9.  Orexin A activates hypoglossal motoneurons and enhances genioglossus muscle activity in rats.

Authors:  G H Zhang; Z L Liu; B J Zhang; W Y Geng; N N Song; W Zhou; Y X Cao; S Q Li; Z L Huang; L L Shen
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 10.  Hypothalamic orexins/hypocretins as regulators of breathing.

Authors:  Rhîannan H Williams; Denis Burdakov
Journal:  Expert Rev Mol Med       Date:  2008-10-02       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.